A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/12027564

Download in:

View as

General Info

PMID
12027564